GILT appears to play a role in Ag cross-presentation by dendritic cells for epitopes recognized by CD8+ T cells [41], but in the case of CD4+ T cell responses to melanoma, cells as well as APC expressions of GILT may impact tumor clearance [15,32,38]. This evidence concerns the gene CD8A and neoplasm.